Home » Topics » Regulatory » Patents

Patents
RSS

Korea research institute describes new compounds with reversible antisecretory activity

April 12, 1999

Chemokine receptor modulators claimed by Merck for HIV/AIDS prevention or treatment

April 12, 1999

Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration

April 9, 1999

Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects

April 9, 1999

Apoptosis-inducing peptide discovered at Morinaga Milk

April 9, 1999

Neurokinin antagonists from Solvay particularly useful for GI disorders

April 9, 1999

Novel anticonvulsants described by RCT

April 9, 1999

Novel compounds from Nippon Kayaku promote neuronal differentiation

April 8, 1999

Dual-action antiasthmatic agents described in patent literature by Kowa

April 8, 1999

Metabolically stable antiadhesion agents in development at Daikin

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.